Spyre Therapeutics Inc. Earnings

The next earnings date for Spyre Therapeutics Inc. is November 6, 2025.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Spyre Therapeutics Inc. Earnings

Report Date	Estimated Earnings Per Share
11/06/2025	$-0.77

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Spyre Therapeutics Inc. Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
08/04/2025	---	$0	100.00%
07/31/2025	---	$0	100.00%
05/13/2025	After Market	$-0.60	28.57%
02/26/2025	After Market	$-0.81	14.22%
11/07/2024	After Market	$-1.36	-65.85%
08/07/2024	After Market	$-0.86	9.47%
05/09/2024	After Market	$-1.20	-2.56%
02/29/2024	After Market	$-4.05	-419.23%
11/09/2023	After Market	$-9.34	-1,011.90%
08/11/2023	---	$-56.25	-1,516.38%
05/11/2023	---	$-4.55	-2,427.78%
03/02/2023	---	$-5	-2,090.10%
11/03/2022	---	$-4.33	-1,632.00%
08/04/2022	---	$-6.75	-2,023.98%
05/05/2022	---	$-9.25	-2,609.43%
03/08/2022	---	$-7.75	-2,595.65%
11/04/2021	---	$-7.75	-2,675.79%
08/05/2021	---	$-2.50	-1,420.68%
05/10/2021	---	$-7	-2,962.12%
03/18/2021	---	$-8.75	-2,451.76%
11/05/2020	---	$-7.25	-1,750.91%
08/10/2020	---	$-10	-2,225.58%
05/07/2020	---	$-14.25	-2,092.31%
02/24/2020	---	$-16.25	-2,325.37%
11/06/2019	---	$-16.50	-2,955.56%
08/06/2019	---	$-13.75	-2,764.58%
05/07/2019	---	$-14.75	-2,581.82%
03/07/2019	---	$-15.50	-4,089.19%
11/08/2018	---	$-13.50	-2,968.18%
08/09/2018	---	$-11.50	-3,094.44%
05/08/2018	---	$-12.25	-2,684.09%
03/13/2018	---	$-9.75	-1,739.62%
11/08/2017	---	$-0.48	12.73%
08/08/2017	---	$-0.47	2.08%
05/18/2017	---	$-0.47	0.00%
03/08/2017	---	$-0.56	-21.74%
11/08/2016	---	$-0.47	14.55%
08/18/2016	---	$-0.46	-6.98%
05/11/2016	---	$-8.48	---

More About Spyre Therapeutics Inc.

Website

https://www.spyre.com

Country

USA

Full Time Employees

Spyre Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing therapeutics for patients living with inflammatory bowel disease (IBD). It develops SPY001, a human monoclonal immunoglobulin G1 antibody designed to bind selectively to the a4ß7 integrin being developed for the treatment of IBD (ulcerative colitis and Crohn's disease). The company is developing SPY002, a human monoclonal antibody (mAb)candidates designed to bind to tumor necrosis factor-like ligand 1A; and SPY120, a combination of SPY001 (anti-a4ß7) and SPY002 (anti-TL1A) antibodies, which are in preclinical studies. In addition, its other early-stage programs include SPY003, an anti-IL-23 mAb; SPY004; SPY130, a combination of anti-a4ß7 and anti-IL-23 mAbs; and SPY230, a combination of anti-TL1A and anti-IL-23 mAbs. The company was formerly known as Aeglea BioTherapeutics, Inc. and changed its name to Spyre Therapeutics, Inc. in November 2023. The company was incorporated in 2013 and is based in Waltham, Massachusetts.

“Spyre Therapeutics Inc. Earnings” Can Refer to the Spyre Therapeutics Inc. Earnings Date

Some people say “Spyre Therapeutics Inc. earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Spyre Therapeutics Inc. position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Spyre Therapeutics Inc. Stock on the Earnings Date

If you own Spyre Therapeutics Inc. stock (SYRE) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Spyre Therapeutics Inc. might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Spyre Therapeutics Inc. shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Spyre Therapeutics Inc. Earnings

You can contact us any time if you would like to ask questions about Spyre Therapeutics Inc. earnings or anything else related to the stock market.